Published trade mark details for 2562827
This information was published on 2025-07-03T17:25:39 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2562827 (IR 1862500) |
| (220) |
26 Feb 2025
|
| (300) |
US, 26 Aug 2024, 98717377
|
| (500) |
The mark consists of the literal elements CULLINAN THERAPEUTICS with a stylized wing appearing over the "I" in CULLINAN.
|
| (511) (510) |
Class 5
Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology. Class 42 Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology. |
| (540) |
|
| (550) | Figurative |
| (730) |
Cullinan Therapeutics, Inc.
|
Find out more about publications on the About page.